Media Coverage Mar 05 2018 Advancing Rare Disease Research Contract Pharma A record number of personalized medicines were approved by the FDA in 2017. Managing Director, Antti Nurmi, Ph.D., explains how early research provides the crucial evidence needed to conduct clinical trials. Read the full article
Media Coverage Q&A: Amid an M&A Flurry At Charles River, Longtime Exec Birgit Girshick Discusses How Covid-19 Has Changed the Game Learn More
